BESS technical due diligence for buyers who care about the real asset, not the polished deck
Oxaide helps investors, lenders, and asset teams test whether reported battery health matches commercially usable reality. The goal is simple: price the asset based on evidence, not vendor optimism.
What serious buyers need answered
How much usable capacity is actually there, what degradation is underway, and whether those findings change revenue assumptions, downside cases, or reserve planning.
Where standard diligence breaks
Warranty packs, BMS screenshots, and availability summaries do not automatically reveal physical condition. They describe the reporting layer, not always the cell reality underneath it.
Why this is high-stakes capital work
BESS deals look excellent on paper until hidden degradation, thermal risk, or operating constraints start eroding IRR. The bigger the deal, the more expensive weak diligence becomes.
What a stronger diligence pass actually includes
Commercial truth before commitment
The point is not to slow the transaction. It is to stop capital from underwriting a battery story the physics cannot support.
Good diligence does not kill good assets. It helps serious buyers move faster with better pricing discipline, stronger protections, and a cleaner post-close operating plan.